Embolic Protection With the Emboliner for Structural Heart Procedures With Extreme Embolic Risk
Emily Tat(Columbia University Irving Medical Center), Tamim Nazif(Columbia University Irving Medical Center), Isida Byku(AID Atlanta), Anton Camaj(Columbia University Irving Medical Center), Torsten P. Vahl(Columbia University Irving Medical Center), Sanjum Sethi(Columbia University Irving Medical Center), Patrick T. Gleason(Columbia University Irving Medical Center), Isaac George(Columbia University Irving Medical Center), Rebecca T. Hahn(Columbia University Irving Medical Center), Vasilis Babaliaros(Columbia University Irving Medical Center), Dr Adam Greenbaum(Columbia University Irving Medical Center)
Cited by 0
Related Papers
Characterization of Myocardial Injury in Patients With COVID-19
|Journal of the American College of Cardiology|2020|429
Coronary In-Stent Restenosis
|Journal of the American College of Cardiology|2022|397
Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair
|Journal of the American College of Cardiology|2022|261
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
|European Heart Journal|2019|203
Left Ventricular Thrombus Following Acute Myocardial Infarction
|Journal of the American College of Cardiology|2022|183